TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial-Reference-Cited by-同舟云学术

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

Published:2011-06 Issue:6 Volume:12 Page:527-539
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bonnefoi Hervé,Piccart Martine,Bogaerts Jan,Mauriac Louis,Fumoleau Pierre,Brain Etienne,Petit Thierry,Rouanet Philippe,Jassem Jacek,Blot Emmanuel,Zaman Khalil,Cufer Tanja,Lortholary Alain,Lidbrink Elisabet,André Sylvie,Litière Saskia,Lago Lissandra Dal,Becette Véronique,Cameron David A,Bergh Jonas,Iggo Richard

Publisher

Elsevier BV

Subject

Oncology

Reference37 articles.

1. Blinded by the light: the growing complexity of p53;Vousden;Cell,2009

2. p53 status and the efficacy of cancer therapy in vivo;Lowe;Science,1994

3. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents;O'Connor;Cancer Res,1997

4. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment;Fan;Clin Cancer Res,1998

5. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis;Wahl;Nat Med,1996

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast Cancers;Genes;2023-12-23

2. ASPP1/2 positive patients with invasive breast cancers have good prognosis;Heliyon;2023-10

3. Association between event-free survival and overall survival in early-stage triple-negative breast cancer;Future Oncology;2023-08-21

4. Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms;Cell Death Discovery;2023-05-13

5. Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy;Genome Medicine;2022-08-11